Debut Plus

4,566.9

-131.07 -2.79%

18 Jul 2026

NSE Listed · Pharmaceuticals

Pfizer Ltd. (PFIZER)

Volume: 32,731Avg Vol 1W: 12,926Avg Vol 1M: 15,48252W Range:4,360.15,873.5
Market Cap₹20,893 Cr
Current Price₹4,566.9
Previous Close₹4,697.97
High / Low (52w)₹5,873.5 / ₹4,360.1
Volume32,731
Avg Vol (1W)12,926
Avg Vol (1M)15,482
Stock P/E104.55
Book Value₹918.71
Dividend Yield1.64%
ROE17.19%
ROA14.68%
Revenue (TTM)
Revenue Growth
Profit Margin28.67%
Total Debt
Shares Outstanding5 Cr
Face Value₹10
EPS (TTM)₹165.84
P/B4.97
Debt / Equity0
50 DMA₹4,549.46
200 DMA₹4,712.85
Day change-2.79%
Price Chart
4,566.9 8.08% · 1Y
525743909.4L
2025-11-24
2026-07-17

20-day avg volume: 15K shares

Pros
  • Healthy return on equity of 17.2%.
  • Pays a dividend yield of 1.6%.
  • Company is almost debt-free.
  • Revenue grew 10% YoY.
Cons
  • Stock trades at a high P/E of 105.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹563 Cr₹589 Cr₹538 Cr₹592 Cr₹603 Cr₹642 Cr₹645 Cr₹629 Cr
EBITDA₹205 Cr₹217 Cr₹174 Cr₹256 Cr₹263 Cr₹258 Cr₹252 Cr₹262 Cr
Net Profit₹151 Cr₹158 Cr₹128 Cr₹331 Cr₹192 Cr₹189 Cr₹142 Cr₹200 Cr
EPS
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹2,249 Cr₹2,336 Cr₹2,320 Cr₹2,674 Cr₹2,526 Cr₹2,374 Cr₹2,454 Cr₹2,708 Cr
EBITDA₹661 Cr₹653 Cr₹684 Cr₹783 Cr₹804 Cr₹754 Cr₹852 Cr₹1,034 Cr
Net Profit₹429 Cr₹509 Cr₹498 Cr₹613 Cr₹624 Cr₹551 Cr₹768 Cr₹722 Cr
EPS93.78111.28108.77133.89136.38120.51167.79157.92
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹3,940 Cr₹4,405 Cr₹3,266 Cr₹3,901 Cr₹4,001 Cr₹4,229 Cr₹4,911 Cr₹4,922 Cr
Total Liabilities₹929 Cr₹1,010 Cr₹873 Cr₹1,036 Cr₹793 Cr₹633 Cr₹694 Cr₹719 Cr
Equity₹3,011 Cr₹3,395 Cr₹2,393 Cr₹2,864 Cr₹3,207 Cr₹3,596 Cr₹4,217 Cr₹4,203 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹536 Cr₹631 Cr₹893 Cr₹658 Cr₹411 Cr₹816 Cr₹953 Cr
Investing₹1,530 Cr₹-469 Cr₹-575 Cr₹-36 Cr₹54 Cr₹-71 Cr₹-562 Cr
Financing₹-164 Cr₹-1,571 Cr₹-181 Cr₹-346 Cr₹-235 Cr₹-205 Cr₹-798 Cr
Free Cash Flow₹536 Cr₹631 Cr₹893 Cr₹658 Cr₹411 Cr₹816 Cr₹953 Cr
Shareholding
Promoter 63.92% Institutions 19.45% Public 16.63%
Efficiency & Working Capital
ROCE23%
Interest Coverage0
Dividend Payout
Debtor Days26 d
Inventory Days68 d
Payable Days31 d
Cash Conversion Cycle64 d
Working Capital Days95 d
Shareholding Details

As of 2026-06-30

Promoter63.9%
FII1.7%
DII17.8%
Institutions19.4%
Public16.6%
Promoter Pledge0%
No. of Shareholders1,02,478
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters63.9%63.9%63.9%63.9%63.9%63.9%63.9%63.9%63.9%63.9%63.9%63.9%
FIIs2.8%3%3.3%3.2%3.5%2.7%2.2%2.4%2.6%2.7%2.8%1.7%
DIIs15%15.1%15.3%15.8%16%16.8%17.1%17.2%17.1%17%16.9%17.8%
Public18.2%17.9%17.4%17%16.5%16.5%16.8%16.5%16.4%16.3%16.4%16.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,16,9481,12,4561,09,2141,06,09898,8241,05,0151,08,2611,03,2221,03,4801,00,93399,5451,02,478
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Pfizer East India B VShareholding of Promoter and Promoter Group39.8%1.82 Cr
Wyeth LlcShareholding of Promoter and Promoter Group12.3%56,17,707
Nippon Life India Trustee LtdPublic Shareholding4.2%19,06,535
Life Insurance Corporation Of IndiaPublic Shareholding3.7%17,09,223
Wyeth Holdings CorporationShareholding of Promoter and Promoter Group3.6%16,30,164
Icici Prudential FundPublic Shareholding3.3%15,14,012
Warner-lambert Company LlcShareholding of Promoter and Promoter Group2.6%11,87,163
Quant Mutual FundPublic Shareholding2.2%10,16,315
Atul LimitedPublic Shareholding2.1%9,58,927
Parke, Davis & Company LlcShareholding of Promoter and Promoter Group2.1%9,55,733
John Wyeth & Brother LtdShareholding of Promoter and Promoter Group1.9%8,82,000
Pharmacia CorporationShareholding of Promoter and Promoter Group1.7%7,83,941
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Wyeth Holdings Corporation00%2026-06-30
John Wyeth & Brother Ltd00%2026-06-30
Warner-lambert Company Llc00%2026-06-30
Wyeth Llc00%2026-06-30
Parke, Davis & Company Llc00%2026-06-30
Pfizer East India B V00%2026-06-30
Pharmacia Corporation00%2026-06-30
Nippon Life India Trustee Ltd00%2026-06-30
Quant Mutual Fund00%2026-06-30
Icici Prudential Fund00%2026-06-30
Life Insurance Corporation Of India00%2026-06-30
Atul Limited00%2026-06-30
Board of Directors
NameDesignationYear
Pradip ShahChairman(Non Exe)&Dir(Non-Ind)2026
MEENA GANESHIndependent Non Exe. Director2026
L KrishnakumarIndependent Non Exe. Director2026
Sonia SinghIndependent Non Exe. Director2026
Meenakshi NevatiaManaging Director & CEO2026
Amit AgarwalExecutive Director - Finance / WTD / CFO2026
P. RenganExecutive Director / Whole Time Director2026
Prajeet NairCS / Director - Corporate Services2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹915 Cr87.2%
Services₹0 Cr0%
Others₹134 Cr12.8%
Segments — Geography
RegionRevenueShare
India₹2,423 Cr96.2%
outside of India₹96 Cr3.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10534646
Corporate Actions
TypeDateValueRemark
dividend2026-07-17₹75 (750%)Final
forthcoming2026-07-17Dividend (75/- per share)Final
dividend2025-07-09₹35 (350%)Final
dividend2025-07-09₹100 (1000%)Special 1
dividend2025-07-09₹30 (300%)Special 2
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202684900174851,352
202670300174851,205
20261460000146
Substantial Acquisitions (SAST)

1 disclosure(s)

Market28/04/2022 · 9,30,573
Company Information
Incorporated1950
ChairmanPradip Shah
AuditorB S R & Co LLP
Investor Email[email protected]
🌐 www.pfizerindia.com

📍 The Capital 1802/1901 Plot-C70, G Bl Bandra Kurla Cpx Bandra-E, Mumbai, Maharashtra, 400051

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search